Bone-targeted pyrido[2,3-d]pyrimidin-7-ones: potent inhibitors of Src tyrosine kinase as novel antiresorptive agents. 2003

Chi B Vu, and George P Luke, and Noriyuki Kawahata, and William C Shakespeare, and Yihan Wang, and Raji Sundaramoorthi, and Chester A Metcalf, and Terence P Keenan, and Selvi Pradeepan, and Evelyn Corpuz, and Taylor Merry, and Regine S Bohacek, and David C Dalgarno, and Surinder S Narula, and Marie Rose van Schravendijk, and Mary K Ram, and Susan Adams, and Shuenn Liou, and Jeffrey A Keats, and Shelia M Violette, and Wei Guan, and Manfred Weigele, and Tomi K Sawyer
ARIAD Pharmaceuticals, Inc., 26 Landsdowne Street, Cambridge, MA 02139-4234, USA.

The design of bone-targeted pyrido[2,3-d]pyrimidin-7-ones as Src tyrosine kinase inhibitors is described. Leveraging SAR from known compounds and using structure-based methods, we were able to rapidly incorporate bone binding components, which maintained, and even increased potency against the target enzyme. Compound 4 displayed a high affinity for hydroxyapatite, a major constituent of bone, and demonstrated antiresoprtive activity in our cell-based assay.

UI MeSH Term Description Entries
D010010 Osteoclasts A large multinuclear cell associated with the BONE RESORPTION. An odontoclast, also called cementoclast, is cytomorphologically the same as an osteoclast and is involved in CEMENTUM resorption. Odontoclasts,Cementoclast,Cementoclasts,Odontoclast,Osteoclast
D011744 Pyrimidinones Heterocyclic compounds known as 2-pyrimidones (or 2-hydroxypyrimidines) and 4-pyrimidones (or 4-hydroxypyrimidines) with the general formula C4H4N2O. Pyrimidinone,Pyrimidone,Pyrimidones
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D001847 Bone Diseases Diseases of BONES. Bone Disease,Disease, Bone,Diseases, Bone
D001862 Bone Resorption Bone loss due to osteoclastic activity. Bone Loss, Osteoclastic,Osteoclastic Bone Loss,Bone Losses, Osteoclastic,Bone Resorptions,Loss, Osteoclastic Bone,Losses, Osteoclastic Bone,Osteoclastic Bone Losses,Resorption, Bone,Resorptions, Bone
D003198 Computer Simulation Computer-based representation of physical systems and phenomena such as chemical processes. Computational Modeling,Computational Modelling,Computer Models,In silico Modeling,In silico Models,In silico Simulation,Models, Computer,Computerized Models,Computer Model,Computer Simulations,Computerized Model,In silico Model,Model, Computer,Model, Computerized,Model, In silico,Modeling, Computational,Modeling, In silico,Modelling, Computational,Simulation, Computer,Simulation, In silico,Simulations, Computer
D003804 Dentin The hard portion of the tooth surrounding the pulp, covered by enamel on the crown and cementum on the root, which is harder and denser than bone but softer than enamel, and is thus readily abraded when left unprotected. (From Jablonski, Dictionary of Dentistry, 1992) Dentine,Dentines,Dentins
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

Chi B Vu, and George P Luke, and Noriyuki Kawahata, and William C Shakespeare, and Yihan Wang, and Raji Sundaramoorthi, and Chester A Metcalf, and Terence P Keenan, and Selvi Pradeepan, and Evelyn Corpuz, and Taylor Merry, and Regine S Bohacek, and David C Dalgarno, and Surinder S Narula, and Marie Rose van Schravendijk, and Mary K Ram, and Susan Adams, and Shuenn Liou, and Jeffrey A Keats, and Shelia M Violette, and Wei Guan, and Manfred Weigele, and Tomi K Sawyer
April 2005, Journal of medicinal chemistry,
Chi B Vu, and George P Luke, and Noriyuki Kawahata, and William C Shakespeare, and Yihan Wang, and Raji Sundaramoorthi, and Chester A Metcalf, and Terence P Keenan, and Selvi Pradeepan, and Evelyn Corpuz, and Taylor Merry, and Regine S Bohacek, and David C Dalgarno, and Surinder S Narula, and Marie Rose van Schravendijk, and Mary K Ram, and Susan Adams, and Shuenn Liou, and Jeffrey A Keats, and Shelia M Violette, and Wei Guan, and Manfred Weigele, and Tomi K Sawyer
February 2023, ACS medicinal chemistry letters,
Chi B Vu, and George P Luke, and Noriyuki Kawahata, and William C Shakespeare, and Yihan Wang, and Raji Sundaramoorthi, and Chester A Metcalf, and Terence P Keenan, and Selvi Pradeepan, and Evelyn Corpuz, and Taylor Merry, and Regine S Bohacek, and David C Dalgarno, and Surinder S Narula, and Marie Rose van Schravendijk, and Mary K Ram, and Susan Adams, and Shuenn Liou, and Jeffrey A Keats, and Shelia M Violette, and Wei Guan, and Manfred Weigele, and Tomi K Sawyer
May 2022, Bioorganic & medicinal chemistry letters,
Chi B Vu, and George P Luke, and Noriyuki Kawahata, and William C Shakespeare, and Yihan Wang, and Raji Sundaramoorthi, and Chester A Metcalf, and Terence P Keenan, and Selvi Pradeepan, and Evelyn Corpuz, and Taylor Merry, and Regine S Bohacek, and David C Dalgarno, and Surinder S Narula, and Marie Rose van Schravendijk, and Mary K Ram, and Susan Adams, and Shuenn Liou, and Jeffrey A Keats, and Shelia M Violette, and Wei Guan, and Manfred Weigele, and Tomi K Sawyer
February 2021, European journal of medicinal chemistry,
Chi B Vu, and George P Luke, and Noriyuki Kawahata, and William C Shakespeare, and Yihan Wang, and Raji Sundaramoorthi, and Chester A Metcalf, and Terence P Keenan, and Selvi Pradeepan, and Evelyn Corpuz, and Taylor Merry, and Regine S Bohacek, and David C Dalgarno, and Surinder S Narula, and Marie Rose van Schravendijk, and Mary K Ram, and Susan Adams, and Shuenn Liou, and Jeffrey A Keats, and Shelia M Violette, and Wei Guan, and Manfred Weigele, and Tomi K Sawyer
June 2016, European journal of medicinal chemistry,
Chi B Vu, and George P Luke, and Noriyuki Kawahata, and William C Shakespeare, and Yihan Wang, and Raji Sundaramoorthi, and Chester A Metcalf, and Terence P Keenan, and Selvi Pradeepan, and Evelyn Corpuz, and Taylor Merry, and Regine S Bohacek, and David C Dalgarno, and Surinder S Narula, and Marie Rose van Schravendijk, and Mary K Ram, and Susan Adams, and Shuenn Liou, and Jeffrey A Keats, and Shelia M Violette, and Wei Guan, and Manfred Weigele, and Tomi K Sawyer
November 2019, Molecules (Basel, Switzerland),
Chi B Vu, and George P Luke, and Noriyuki Kawahata, and William C Shakespeare, and Yihan Wang, and Raji Sundaramoorthi, and Chester A Metcalf, and Terence P Keenan, and Selvi Pradeepan, and Evelyn Corpuz, and Taylor Merry, and Regine S Bohacek, and David C Dalgarno, and Surinder S Narula, and Marie Rose van Schravendijk, and Mary K Ram, and Susan Adams, and Shuenn Liou, and Jeffrey A Keats, and Shelia M Violette, and Wei Guan, and Manfred Weigele, and Tomi K Sawyer
October 2014, European journal of medicinal chemistry,
Chi B Vu, and George P Luke, and Noriyuki Kawahata, and William C Shakespeare, and Yihan Wang, and Raji Sundaramoorthi, and Chester A Metcalf, and Terence P Keenan, and Selvi Pradeepan, and Evelyn Corpuz, and Taylor Merry, and Regine S Bohacek, and David C Dalgarno, and Surinder S Narula, and Marie Rose van Schravendijk, and Mary K Ram, and Susan Adams, and Shuenn Liou, and Jeffrey A Keats, and Shelia M Violette, and Wei Guan, and Manfred Weigele, and Tomi K Sawyer
November 2000, Journal of medicinal chemistry,
Chi B Vu, and George P Luke, and Noriyuki Kawahata, and William C Shakespeare, and Yihan Wang, and Raji Sundaramoorthi, and Chester A Metcalf, and Terence P Keenan, and Selvi Pradeepan, and Evelyn Corpuz, and Taylor Merry, and Regine S Bohacek, and David C Dalgarno, and Surinder S Narula, and Marie Rose van Schravendijk, and Mary K Ram, and Susan Adams, and Shuenn Liou, and Jeffrey A Keats, and Shelia M Violette, and Wei Guan, and Manfred Weigele, and Tomi K Sawyer
May 2013, Archives of pharmacal research,
Chi B Vu, and George P Luke, and Noriyuki Kawahata, and William C Shakespeare, and Yihan Wang, and Raji Sundaramoorthi, and Chester A Metcalf, and Terence P Keenan, and Selvi Pradeepan, and Evelyn Corpuz, and Taylor Merry, and Regine S Bohacek, and David C Dalgarno, and Surinder S Narula, and Marie Rose van Schravendijk, and Mary K Ram, and Susan Adams, and Shuenn Liou, and Jeffrey A Keats, and Shelia M Violette, and Wei Guan, and Manfred Weigele, and Tomi K Sawyer
September 2020, Heliyon,
Copied contents to your clipboard!